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1. Introduction     
Over the last decade, a tremendous progress has been made regarding our understanding of 
the molecular program involved in early human development. The main reason behind 
these advancements can be ascribed to the successful isolation of human embryonic stem 
cell (hESC) lines in the late 1990’s. Based on their fundamental properties of pluripotency 
and unlimited proliferation, these unique cells have provided the possibility to study early 
human developmental processes in vitro. However, there are many obstacles to overcome 
before the potential of these cells can be fully realized. One important issue is to increase the 
understanding about the gene regulatory mechanisms that control the differentiation of 
hESCs. A wide variety of tools and technologies have been used to manipulate and study 
basic hESC characteristics and functions. Furthermore, the parallel analysis of functional 
derivatives of hESCs has provided important insights into the mechanisms that govern their 
differentiation into specific cell lineages. Global transcriptional changes in cells and tissues 
can be studied using molecular techniques such as DNA microarray, EST-enumeration, 
MPSS profiling, and SAGE. The results from such experiments provide a snapshot of the 
status of the cells under study. This approach has proven well suited for characterization of 
the “stemness” state of hESCs, but also for the identification of crucial pathways involved in 
their differentiation. Large scale gene expression databases have been generated using 
various hESC lines and technical platforms, and subsequently the information has been 
analyzed using different bioinformatic approaches. A discrete set of genes has been 
identified which are highly expressed in hESCs, and these genes are considered to be 
involved in preserving the pluripotency and self-renewal capacity of the undifferentiated 
cells. Furthermore, several studies have focused on characterizing the molecular signature of 
specific differentiation processes. Again, global expression analysis has proven to be a very 
suitable tool since novel important mechanisms can be revealed in the context of such 
experiments. More recently, the possibility to analyze also the global expression profile of 
microRNA (miRNA) has been realized, and microarray based platforms designed 
specifically for the detection of miRNA species are now available. The concurrent analysis of 
the global mRNA and miRNA expression profiles of hESCs and their differentiated progenies 
are anticipated to provide additional insights into the regulatory pathways which are active in 
the cells in the undifferentiated and differentiated states. In the present chapter, we will 
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discuss issues regarding the platforms used and the bioinformatic tools applied to interpret the 
results and also review some important studies on transcriptional profiling of hESCs. 
2. Gene transcription and protein translation 
Gene expression is the process by which information from a gene is copied from the gene to 
an mRNA sequence, which is then used in the synthesis of a functional gene product, a 
protein. The properties of the expression products give rise to the phenotype of an 
organism. When conducting gene expression studies, it is important to understand the basic 
concepts behind these processes, for a proper interpretation of the data. The genetic code is 
mediated by the gene expression, and the process from transcription of a gene to a 
functional protein involves several steps, such as transcription of the gene in the nucleus, 
and transport of the mRNA to the cytoplasm where translation to a protein is carried out 
aided by ribosomes. What is usually measured with microarrays is the amount of mRNA in 
the cell. However, in recent years, the microarray technology has also been successfully used 
for assessment of miRNA expression and moreover, protein arrays have begun to enter the 
market. By means of gene regulation the cell has control over its structure and function, and 
this is the basis for cellular differentiation, morphogenesis, and the versatility and 
adaptability of any organism. Transcriptional regulation is also essential for evolutionary 
changes, since control of the timing, location, and amount of gene expression often have 
profound effects on the functions of the gene in a cell.  
2.1 Transcriptional regulation 
The transcription of genes involves intricate dynamic dependencies which makes it 
challenging to study. Several mechanisms have been shown to be critical for the initiation of 
transcription, the rate of transcription, and the subsequent processing of the mRNA. These 
regulatory mechanisms control when the transcription occurs and the amount of mRNA 
produced. The transcription of a gene is carried out by RNA polymerase and the process is 
regulated by several components (Alberts et al., 2004):  
- Specificity factors control the ability for the RNA polymerase to bind to a specific 
promoter or set of promoters.  
- Repressors bind to non-coding regions, close to or overlapping with the promoter for a 
gene, and impede the RNA polymerase’s progress along the DNA strand, thus 
hampering the transcription of the gene.  
- General transcription factors aid in positioning the RNA polymerase at the start of a 
protein coding sequence.  
- Activators enhance the interaction between the RNA polymerase and the specific 
promoter.  
- Enhancers are sites on the DNA helix that are bound to by activators in order to loop the 
DNA and bring a specific promoter to the initiation complex.  
As microarrays provide the opportunity to globally monitor the transcriptome and the 
expression of interacting molecules, they provide a powerful tool for studies of 
transcriptional regulation.  
2.2 Splicing of mRNAs 
Splicing is a modification of an RNA sequence post-transcription, in which introns are 
removed and exons are joined together (Fig. 1.) Hence, after transcription of a gene, the pre-
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mRNA is spliced to mRNA, which is often performed in a series of reactions. RNA splicing 
allow for packing of more information into every gene as the transcripts from one single 
gene can be spliced in various ways to produce different mRNAs, depending on the cell 
type in which the gene is being expressed or the stage of the development of the organism 
(Alberts et al., 2004). As a consequence, different proteins can be produced by the same gene 
and it is estimated that 60% of the human genes undergo such alternative splicing (Alberts 
et al., 2004). Thus, RNA splicing increases the already enormous coding potential of 
eukaryotic genomes, at the same time as it complicates the studies of gene transcription. 
This is because the complexity increases dramatically when there, as in many cases, are 
several different transcripts transcribed by one single gene.  
 
Fig. 1. Splicing of pre-mRNA where introns are removed before formation of the mRNA 
sequence. Different sets of exons can be selected to form the mRNA, which means that one 
pre-mRNA can give rise to several variants of mRNA sequences. 
2.3 Translation to protein 
After the splicing, the mRNA transcript is transported from the nucleus to the cytoplasm 
where the translation occurs by means of ribosomes. The same mRNA sequence can be 
translated many times, and therefore the period of time that a mature mRNA molecule 
persists in the cell, influences the amount of protein that is produced. The lifetime of 
mRNAs differs considerably and cannot be assessed by using single time point microarray 
analyses, as these only gives a snap-shot of the amount of mRNA at a specific time point. 
The mRNA lifetime is dependent on a multitude of factors, such as the nucleotide sequence 
of the mRNA itself, as well as the type of cell in which the mRNA is produced. The typical 
lifetime for mRNA molecules in eukaryotic cells ranges from 30 minutes up to 10 hours 
(Alberts et al., 2004). In the ribosome the nucleotide sequence is translated into an amino 
acid sequence by means of the genetic code. The sequence of nucleotides in the mRNA is read 
in groups of three, codons, and each codon specifies one amino acid. Depending on where in 
the sequence the de-coding begins, each mRNA sequence can be translated in three 
different, non-overlapping, reading frames but only one of these is the correct one (Alberts 
et al., 2004). To control that correct reading frame are used, the translation of an mRNA 
begins with a specific start codon (AUG), and is then performed in the direction 5’ cap to 3’ 
end. The end of a protein coding mRNA is indicated by the presence of one of three stop 
codons (UAA, UAG, UGA) which signal to the ribosome to stop the translation. 
3. MicroRNAs 
An additional level of cellular regulation involves a family of tiny molecules, known as 
miRNAs. These are 19–25 nucleotides non-coding RNAs that bind to the 3′ untranslated 
region of target mRNAs through imperfect matching. In mammalian genomes miRNAs are 
predicted to regulate the expression of approximately 30% of the protein-coding genes 
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(Bartel, 2004). Knowledge about the biological functions of most miRNAs identified thus far 
is still lacking, but it has been shown that they play important roles in embryo development, 
determination of cell fate, cell proliferation, and cell differentiation (Sartipy et al., 2009, 
Wang et al., 2009). MicroRNAs are derived from approximately 70 nucleotide long 
precursors, encoded by introns or intergenic regions, and are expressed in most organisms 
ranging from plants to humans. Many miRNAs appear to be expressed at different levels in 
various tissues, and the maturation and function of the tissues seem to be influenced by 
their presence. Interestingly, results from recent studies have indicated important roles for 
miRNAs in the control of diverse aspects of heart formation and cardiac function (Ivey et al., 
2008, van Rooij & Olson, 2007). It is also known that miRNAs are involved in various types 
of cancer by targeting tumor suppressing genes (Lu et al., 2005, Zhu et al., 2008). 
MicroRNAs bind to their target mRNAs and negatively regulate their expression, either by 
repression of translation or by degradation of the mRNA (Bartel, 2004). Increased expression 
levels of miRNAs can also result in up-regulation of previously suppressed target genes 
either directly, by decreasing the expression of inhibitory proteins and/or transcription 
factors, or indirectly, by inhibiting the expression levels of inhibitory miRNAs (Gregory et 
al., 2008). Depending on the state of the cell, miRNAs have also been observed to affect the 
translation of target mRNAs by regulation of their stability (Gregory et al., 2008, Vasudevan 
et al., 2007). Moreover, it has been shown that combinatorial regulation by miRNAs is 
common, which enables complex regulatory programs that are exceptionally challenging to 
dissect (Zhou et al., 2007).  
4. Global transcriptional profiling techniques 
There are several high throughput techniques for measuring gene expression at the large 
scale, such as expressed sequence tags (EST)-enumeration, Serial Analysis of Gene 
Expression (SAGE), Massively Parallel Signature Sequencing (MPSS) and different types of 
microarrays (described in more detail below). In EST-enumeration the expression levels are 
assessed by counting the number of ESTs for a particular gene, randomly selected from a 
cDNA library derived from the sample. The ESTs are clustered into groups of sequences 
originating from the same transcript, and subsequently assembled to achieve a longer 
consensus sequence, which is then aligned to the genome to find the matching gene 
sequence. Both SAGE and MPSS are sequencing based techniques that use tags to identify 
and count the mRNAs, but the biochemical manipulation and the sequencing approaches 
differ substantially between these techniques. Both methods are based on the principle that 
a short sequence tag contains sufficient information to uniquely identify a transcript, 
provided that the tag is obtained from a specific position within each transcript. In SAGE, 
short tags, usually 9-10 base pairs in length, are extracted from each mRNA, at a defined 
position. These tags are then linked together to form long serial molecules that can be cloned 
and sequenced. The quantification is performed by counting the number of times a specific 
tag is observed in the sequenced molecule. Finally, the tags are matched to the 
corresponding genes.  
In MPSS, the extracted signatures are longer, 17-20 base pairs. Every one of these signatures 
is cloned into a vector and labeled with a unique 32 base pair oligonucleotide tag. The tag is 
then attached to one of millions of microbeads, by hybridization of the tag to a 
complementary sequence on the bead. The signatures on the microbeads are then sequenced 
and matched to the corresponding genes, and subsequently quantified by counting the 
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number of beads. The longer tag sequences, used in MPSS, provide higher specificity 
compared to SAGE. Another advantage of MPSS is the larger library size. One disadvantage 
that applies to both SAGE and MPSS is the loss of certain transcripts due to lack of 
restriction enzyme recognition sites, and ambiguity in tag annotation. Compared to 
microarray techniques, sequencing techniques, which are not based on hybridizations, give 
on the other hand a more exact quantitative value. This is because the number of transcripts 
is counted directly, instead of quantifying spot intensities which is prone to background 
noise. Another advantage is that the mRNA sequences do not need to be known beforehand, 
and therefore also previously unknown transcripts can be detected. Nevertheless, 
microarray experiments are much cheaper to perform and are therefore usually used in 
large scale experiments. 
4.1 Microarray technology 
The microarray technology has been around since the early 1990s, and during the last two 
decades the precision of the technology has increased considerably and, at the same time, 
the cost has decreased. Microarrays render the possibility to monitor the expression of 
thousands of genes simultaneously, which make them exceptionally useful for 
transcriptional studies on the global scale. Investigators are using the microarray technology 
to try to understand fundamental aspects of growth and development as well as to explore 
the underlying genetic causes of many human diseases. By monitoring the cells at various 
time points during a biological process or at specific biological conditions, one can take 
snapshots of the global transcriptional profile at different stages. The principle behind the 
microarray technology is base pairing of DNA/RNA. When two complementary sequences 
come together, such as the immobilized probe on the array and the mobile target in the 
sample, they will lock together (hybridize). The microarray consists of a surface on which 
millions of probes are immobilized. The surface is divided into features (locations), and each 
feature on the microarray has a superfluous number of probes that correspond to a specific 
transcript. When labeled target transcripts are hybridized onto the microarray, these bind 
complementary to their probes. The general procedure for performing a microarray 
experiment (which varies somewhat depending on the type of system) includes a series of 
steps. Initially, the RNA is reverse transcribed, usually to cDNA, and labeled with a 
fluorophore, and then the solution is hybridized onto the array. After the hybridization, the 
arrays are thoroughly washed, rinsed, and dried to remove non-hybridized transcripts from 
the surface. They are subsequently scanned to measure the fluorescence intensity for each 
spot on the array and these intensities are then translated into expression values. The spot 
intensities are directly proportional to the number of transcripts corresponding to each gene, 
and thus to the expression level of the gene. 
4.2 Different types of microarrays 
There are many different types of microarrays and the broadest distinction is whether the 
probes are spatially arranged on a slide made of glass, silicon or plastic or, if they are coded 
on microscopic polystyrene beads. They can be fabricated using different techniques, where 
the most common ones are robotic printing of the spots on the array (spotted arrays) or 
synthesis of the probes in situ using techniques such as photolithography. Moreover, the 
arrays vary in the way the signals are detected, and they are designed for hybridization of 
either one or two samples on the same array (one- or two-channel arrays) (Fig. 2).  
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Fig. 2. Schematic picture of one-channel hybridization (A) and two-channel hybridization 
(B). Round-shaped features contain superfluous identical probes that hybridize with labeled 
targets from the samples. The shape of the features may vary between different microarray 
platforms. The intensity of the color is proportional to the number of probes that are 
hybridized to that feature. Yellow color means equal amounts of red and green labeled 
targets. 
On one-channel arrays (also called oligonucleotide arrays) only one sample can be 
hybridized on each array, and the intensity levels are measured rather than the ratio 
between two intensities. Therefore, comparison of two conditions requires two separate 
single-dye hybridizations. On two-channel arrays two samples are labeled with two 
different fluorophores, typically Cy3 and Cy5, which have different fluorescence emission 
wavelengths. The two Cy-labeled cDNA samples are mixed and hybridized to a single 
microarray. Since the fluorophores have different excitation wavelengths it is possible to 
split the two signals during the scanning and calculate the intensities of each fluorophore, 
and use this in ratio-based analysis to identify up- and down-regulated genes. One benefit 
of one-channel arrays is that the data is more easily compared to data from different 
experiments, as long as batch effects have been accounted for. However, using the one-color 
system may require twice as many microarrays to compare samples within an experiment 
than with the two-color system. Depending on which system is used, the experimental 
design, and the generated data, the subsequent data analysis may differ. 
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4.3 Affymetrix microarrays 
The Affymetrix platform is the most widely used commercial platform, providing a whole 
range of different types of arrays and covering various species. Affymetrix arrays are in situ 
synthesized, applying the photolithography technology to synthesize thousands to millions 
of 25-mer cDNA oligonucleotides in parallel. By using light-sensitive masking agents, a 
sequence is "built" one nucleotide at a time across the entire array. Typical for Affymetrix 
arrays are the multiple (11–20) probe pairs for each transcript. A new type of Affymetrix 
arrays which recently have entered the market is the Whole Transcript arrays, including 
both Gene ST 1.0 and Exon ST 1.0 arrays (Pradervand et al., 2008). The characteristics of 
these arrays are that they have an increased number of probes targeting exons along the 
whole transcript and not only in the 3’ end. The Gene ST 1.0 array has 1-2 probes per exon 
and the more comprehensive Exon ST 1.0 has four probes per exon.  
4.4 Reliability and reproducibility of microarray data 
The microarray technology has had tremendous impact on gene expression analysis during 
the last decade. However, publications of studies with dissimilar or even contradictory 
results have raised concerns regarding the reliability of this technology (Draghici et al., 2006, 
Kuo et al., 2002, Tan et al., 2003). For example, several global gene expression studies of stem 
cells have shown poor overlap (Fortunel et al., 2003, Ivanova et al., 2002, Ramalho-Santos et 
al., 2002). To address these and other concerns, such as performance and data analysis 
issues, the MicroArray Quality Control project (Chen et al., 2007, Shi et al., 2006) was 
initiated by the US Food and Drug Administration. Using an impressive number of 
laboratories, this comprehensive study showed both intra-platform consistencies across 
laboratories and a high level of inter-platform concordance in terms of genes identified as 
differentially expressed genes. Nevertheless, there are several issues to be aware of when 
using this technology, and which can introduce substantial biases in the final results. 
Examples of such issues to consider are: 
- Cross-hybridization: There is a risk that some mRNAs may cross-hybridize probes on 
the array that are supposed to detect other mRNAs.  
- Fold change compression: Due to various technical limitations, such as limited dynamic 
range and signal saturation, a certain level of FC compression is expected for array data 
compared to e.g. RT-PCR data (Wang et al., 2006, Yuen et al., 2002).  
- Poor sensitivity for low expressed transcripts: Problems with relatively poor sensitivity 
in detecting small FCs have been reported for several microarray platforms (Wang et 
al., 2006). 
- Cross-platform inconsistency: Inconsistent probe annotations across platforms, which 
leads to difficulties to ascertain that probes on various platforms aimed at the same 
gene do in fact quantify the same mRNA transcript (Draghici et al., 2006). 
- Dye-biases: In two-channel systems the fluorescent dyes usually have different dynamic 
ranges and quantum yields, which is partially adjusted for by appropriate 
normalization, but may not be completely eliminated. 
- Non-biological variations: There is always a risk that variations may be introduced 
during the experimental procedure (e.g. different persons performing the experiment, 
minor variations in temperature or duration) (Frantz, 2005) and these sometimes add 
substantial noise to the system. However, this source of variation is not unique to 
microarray experiments but is also an issue in other reverse transcription reactions 
(Wang et al., 2006). 
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5. Bioinformatic and statistical analysis 
Large scale gene expression experiments generate enormous datasets that are 
computationally demanding to analyze. Therefore, gene expression analysis is one research 
area where bioinformatic methods have had important impact. These datasets are often 
challenging to analyze because of complex dependencies of interacting molecules and the 
data is often fragmented, incomplete, and noisy. Today, there are a lot of tools and software 
available, both commercially and open source, for solving various bioinformatic problems, 
such as identification of differentially expressed genes, clustering of data, and identification 
of interaction networks.  
5.1 Data analysis of microarray data 
The raw data from microarray experiments need to be pre-processed in several steps, before 
conducting any high level data analysis. Depending on the array type and the platform, 
these pre-processing steps vary, but basically involve subtraction of background and 
normalization for removal of non-biological variations. The data is also typically log2-
transformed to achieve roughly normally distributed data, and potential outliers are 
excluded before performing the high level analysis. Due to the large amounts of data 
generated in microarray experiments, advanced bioinformatic algorithms (described below) 
are required for efficient interpretation of the data into valuable biological information. In 
the area of gene expression analysis there are e.g. algorithms for:  
- identification of differentially expressed genes  
- clustering of gene expression data 
- pathway analysis 
- derivation of protein interaction networks 
- functional annotation of regulated genes 
Although requiring some programming skills, the freely available R software environment1 
is highly recommended for various analyses of microarray data. This software has packages 
for normalization/standardization and statistical computing, as well as graphics. R can be 
used as a powerful standalone programming language, but the most prominent advantages 
are indeed all the implemented functions that are ready to use, and which make the R 
environment both flexible and extendible.  
5.2 Identification of differentially expressed genes 
There are several approaches on how to determine which genes that are differentially 
expressed in large gene expression datasets. Traditionally, researchers have applied 
different statistical tests and used the p-values as selection criteria. However, when dealing 
with microarray data one has to consider the multiple testing problem, as these datasets 
usually contain thousands of genes and the statistical test is applied for each of these genes. 
In other words, the multiple testing problem means that thousands of hypotheses are tested 
simultaneously, which leads to an increased chance of false positives. Individual p-values of 
a specified significance threshold no longer correspond to significant findings and thus, 
there is a need to adjust for multiple testing when assessing the statistical significance of 
genes in large microarray datasets. One such example of adjustment is Bonferroni 
                                                 
1 http://www.r-project.org 
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correction, where the significance threshold is divided by the number of tests performed. 
However, this is often too strict criteria to be useful, and therefore other methods that are 
more adopted for analysis of microarray data have been developed. Examples of such 
methods are Significance Analysis of Microarray Data (SAM) (Tusher et al., 2001) and 
Empirical Bayes Analysis of Microarrays (EBAM) (Efron & Tibshirani, 2002), both included 
in the Siggenes package2. SAM and EBAM are statistical methods that controls for the false 
discovery rate (FDR), which is the fraction of false positives in the total set of genes that are 
selected as differentially expressed. The FDR is determined by using permutations of the 
repeated measurements to estimate the percentage of genes identified by chance. Although 
statistical methods usually are preferable since they provide a significance measure, the 
simple Fold Change (FC) method which calculates the ratio between two samples, are also 
frequently used. However, since FC provides no statistics regarding the significance of the 
results, combinations of FC and statistical methods are sometimes applied.  
5.3 Clustering of gene expression data 
To reduce the dimensionality and facilitate interpretation of microarray data one can apply 
different clustering techniques, such as hierarchical clustering, K-means (Świniarski et al., 
1998), principle component analysis (PCA) (Jolliffe, 1986) or self-organizing maps (SOMs) 
(Tamayo et al., 1999), to group transcripts with similar transcriptional profiles. The purpose 
of clustering is to identify co-regulated and functionally related genes in large data sets. 
Clustering can also be used as a quality control tool to check the reproducibility of 
replicated arrays. For this purpose the agglomerative hierarchical clustering approach is 
most common. It starts with clusters containing a single item, and iteratively links and 
merges the two closest clusters together based on a distance measure. After each step, all the 
distances between the newly formed clusters are re-calculated. The output is a relationship 
tree (dendrogram) where the branches represent similarity and where the replicated arrays 
are expected to be grouped tightly together. 
5.4 Pathway analysis 
There are two main approaches for identification of pathways that are differentially 
expressed across various experimental conditions. These are Individual Gene Analysis 
(IGA) methods and Gene Set Analysis (GSA) methods (Nam & Kim, 2008). IGA is the most 
widely used approach and evaluates the significance of individual genes between two 
groups of compared samples. Methods using this approach typically yield a list of 
differentially expressed genes from a cutoff threshold, and evaluate this list for the 
enrichment of genes participating in specific pathways from a pathway database. A 
limitation with IGA approaches is that the final result is significantly affected by the selected 
threshold, which is often arbitrarily chosen. Notably, many genes with moderate, but 
biologically meaningful expression differences, are discarded by a strict cutoff threshold, 
which implies a reduction in statistical power. The GSA approach directly scores pre-
defined pathways or gene sets based on differential expression, and specifically aims to 
identify pathways with subtle but coordinated expression changes that cannot be detected 
by IGA methods (Mootha et al., 2003, Nam & Kim, 2008). It is based on the principle that 
even weak expression changes for groups of related genes can have important effects. From 
                                                 
2 http://www.bioconductor.org 
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a biological perspective, GSA methods are promising because functionally related genes 
often display coordinated expression (Nam & Kim, 2008). Various bioinformatic resources 
are available for carrying out pathway analysis such as WebGestalt3 and DAVID4 for the 
IGA approach, and GSEA5 for the GSA approach. 
5.5 Protein interaction networks 
Protein–protein interactions are of central importance for virtually every biological process 
in a living cell. Typically, signal transduction, where mechanical/chemical stimuli to a cell 
are converted into specific cellular responses, plays a fundamental role in many biological 
processes and in many diseases. To investigate the putative interactions among proteins 
from the significantly up- or down-regulated genes identified from a biological experiment, 
protein interaction networks can be computationally generated by combining the 
experimental data with information from interaction databases. Several tools to aid 
derivation of protein interaction networks are available and currently one of the most 
comprehensive is STRING6, which is a freely available database and web resource for 
experimentally determined and predicted protein-protein interactions (Jensen et al., 2009, 
von Mering et al., 2007). STRING includes both physical and functional interactions, and it 
weights and integrates information from numerous sources, including experimental 
repositories, computational prediction methods and public text collections. Thus, STRING is 
acting as a meta-database that maps all interaction evidence into a common set, which is 
then graphically visualized in a protein interaction network (Fig. 3). 
 
 
Fig. 3. Example of a protein interaction network generated by STRING, using pluripotency 
marker genes as input. 
5.6 Functional annotation of differentially expressed genes 
To increase our understanding of the biological properties of differentially expressed genes 
and further explore their functional properties, one can also use annotation information 
from Gene Ontology (Ashburner et al., 2000) which has annotation terms describing the 
                                                 
3 http://bioinfo.vanderbilt.edu/webgestalt/ 
4 http://david.abcc.ncifcrf.gov/ 
5 http://www.broadinstitute.org/gsea/ 
6 http://string-db.org/ 
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genes or gene products. Gene Ontology consists of three categories of annotation terms, 
Biological Processes, Molecular Functions and Cellular Components. By comparing with a 
reference list, overrepresentation of annotations among sets of genes can be calculated by 
dividing the observed number of genes holding a specific annotation with the expected 
number of genes with that annotation. A common tool for Gene Ontology enrichment 
analysis is AmiGO7, but also e.g. WebGestalt8 and DAVID9 provide similar functions. 
6. Problems to address with transcriptional profiling 
Presently, one of the main bottlenecks in stem cell research is insufficient yield and purity of 
the final cell preparations and immature phenotypes of the differentiated cells. There are 
substantial gaps in our understanding of the molecular programs that govern early cellular 
differentiation and maturation, which limits the possibilities to improve the culturing 
protocols. In order to fully realize the potential of hESCs, a better understanding of the 
regulatory mechanisms that control their differentiation towards specific lineages is needed. 
An extensive characterization of hESCs and their derivates is also urgently required. To 
address these challenges, information is needed about which genes that are differentially 
expressed at specific stages during differentiation. Some of these are likely candidate genes 
in regulatory mechanisms, important for transitions of cells between different 
developmental stages. We also need precise characterization methods to determine the 
identity of cells during the differentiation process, and therefore more reliable marker genes 
for specific developmental stages are required. In next chapter we describe how microarray 
technology can been applied to analyze global gene expression patterns in hESCs and their 
differentiated progenies. Below are some examples studies, with focus on cardiac- and 
hepatic lineages, described in more detail. 
7. Examples of transcriptional profiling of hESCs and their derivatives 
Several global gene expression studies have been conducted on hESCs and differentiated 
progenies thereof. Depending on the research questions addressed, these studies have had 
different experimental designs and they have used different analysis approaches.  
7.1 Transcriptional profiling of hESC-derived cardiomyocytes 
The first example is a study where hESC-derived cardiomyocyte clusters (CMCs) were 
characterized at the gene expression level and their global transcriptional pattern was 
investigated (Synnergren et al., 2008). This required only a rather simple design with not 
more than two groups to compare, undifferentiated (UD) hESCs and hESC-derived CMCs. 
The material consisted of one pooled sample of UD hESCs and two different biological 
replicates of pooled hESC-derived CMCs, harvested at a number of time points up to 22 
days after initiation of differentiation (Fig. 4). 
                                                 
7 http://amigo.geneontology.org/cgi-bin/amigo/go.cgi 
8 http://bioinfo.vanderbilt.edu/webgestalt/ 
9 http://david.abcc.ncifcrf.gov/ 
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Fig. 4. Experimental design where two different groups (UD and CMC) were included and 
the experiment was repeated twice using one- and two-cycle amplification respectively. 
The hESC line SA002 (Cellartis AB, Göteborg) was used in this experiment. Due to technical 
issues, two separate sets of microarray experiments were conducted. In the first, one-cycle 
amplified RNA was used, while in the second set of experiments two-cycle amplified RNA 
was used due to the limited amount of available RNA. Even though no obvious differences 
between the two data sets could be observed, all subsequent calculations between samples 
were conducted within each experiment separately. The quality of the RNA and cRNA, 
labeled by in vitro transcription, was tested and the fragmented cRNA was then hybridized 
to the microarrays. Each sample was hybridized to duplicate arrays from the Affymetrix 
microarray platform (GeneChip 133 Plus 2.0) (Affymetrix, Santa Clara, CA). Extraction of 
expression values and scaling of data was performed using the MAS5 algorithm and 
transcripts flagged as ‘Absent’ on all arrays were filtered before the data analysis. The SAM 
statistical algorithm was used to identify significantly up- and down-regulated genes 
between the CMCs compared to UD cells. In total 530 genes were identified as up-regulated 
and 40 genes were down-regulated in the CMCs (Synnergren et al., 2008). These sets of 
regulated genes were further analyzed using various bioinformatic tools. To further explore 
the biology of the significantly up-regulated genes in hESC-derived CMCs, Gene Ontology 
annotations were used to group the genes according to biological process, molecular 
function, and cellular component. To investigate possible interactions among proteins from 
the significantly up-regulated genes in hESC-derived CMCs, the search tool STRING was 
applied to derive protein interaction networks. These networks were used to identify hub-
proteins, with many interactions to other genes. Moreover, differentially expressed 
pathways were assessed in the CMCs using the WebGestalt tool. 
7.2 Investigation of putative correlation between mRNA and miRNA expression 
This second example describes how transcriptional profiling can be applied to further our 
understanding of the regulatory mechanisms of transcription and translation, by 
investigation of putative correlation between mRNA and miRNA expression. Thus, mRNA 
and miRNA microarray experiments were designed where matched samples from hESCs 
and hESC-derived CMCs were collected for global mRNA and miRNA profiling. Using cell 
line SA002 (Cellartis AB, Göteborg) total RNA was extracted with a method which preserves 
small molecules. The RNA was split into two aliquots, and microarray experiments were 
conducted in parallel to measure both miRNA and mRNA expression of paired samples.  
As illustrated in Fig. 5, the material consisted of samples of UD cells and hESC-derived 
CMCs, cultured for 3 (CMC3w) and 7 weeks (CMC7w) after onset of differentiation. In 
addition, samples from fetal heart (FH) and adult heart (AH) were included as reference 
material. Significantly up- or down-regulated miRNAs and mRNAs were identified using 
the SAM statistical algorithm. The differentially expressed miRNAs were grouped  
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Fig. 5. Experimental design of a parallel miRNA and mRNA study. Three time points (UD, 
CMC 3 weeks, and CMC 7 weeks) were analyzed and fetal heart (FH) and adult heart (AH) 
were included as reference samples. 
according to their expression profiles using hierarchical clustering. Putative target genes of 
up- and down-regulated miRNAs were predicted using the tool microT10, and to investigate 
if the predicted target genes are present in the set of differentially expressed mRNAs, the 
overlap between predicted target genes and differentially expressed mRNAs were 
calculated. To further explore the molecular biology of the regulated target genes these were 
also analyzed for enrichment of Gene Ontology annotations related to cardiac development. 
7.3 Transcriptional comparison between two endoderm differentiation protocols 
The final example describes a transcriptional comparison between hESCs differentiated 
through the endoderm, either definitive endoderm (DE) or primitive endoderm (PrE), as 
well as a global transcriptional characterization of endoderm, hepatocyte progenitors, and 
hepatocyte-like cells (Synnergren et al., 2010a). A comprehensive experimental design was 
applied in this work including three cell lines (SA002, SA167, and SA461) and four time 
points, as well as the two separate differentiation protocols (Fig. 6). 
The hepatocellular carcinoma cell line (HepG2) was included as a reference sample in the 
experiment. Each sample was cultured and harvested in biological duplicates. The RNA was 
extracted and assessed for quality before generation of cRNA, and subsequently hybridized 
to the arrays. The raw data was extracted and normalized using MAS5 and filtered and log2 
transformed before subsequent data analysis. In this experiment, the FC method was 
applied to identify differentially expressed genes at various stages. At the early time points 
these cells showed relatively large variations in the magnitude of up- or down-regulation of 
genes across the cell lines. However, the trend of the regulation was consistent in all three 
cell lines and therefore an interesting observation. In such situation, the statistical methods 
have problems to select genes of real biological interest, and consequently FC may be a 
preferable alternative. The DE differentiation pathway to generate hepatocytes mimics the 
development of hepatocytes in the embryo and the expression profiles in these samples  
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Fig. 6. Experimental design of the protocol comparison experiment. Four time points (UD, 4 
days, 10 days, and 20 days) and two differentiation protocols (PrE and DE) were included in 
the experiment which was run in duplicates and repeated using three different cell lines. 
HepG2 was included as a reference sample in the study.  
were therefore characterized in more detail. The genes that showed up-regulation in DE20 
samples compared to UD samples were further analyzed for enrichment of Gene Ontology 
annotations and differentially expressed pathways were also identified using the DAVID 
bioinformatic resource. Moreover, protein interaction networks were derived using the 
STRING tool and based in these, hub proteins were identified among the up-regulated 
genes in DE20 samples.  
8. Results and discussion 
Extensive characterization of hESC-derived functional cell types, such as cardiomyocytes 
and hepatocytes has been performed by several investigators, with the purpose to explore 
the transcriptional programs that are activated during differentiation along these specific 
lineages. Results from these studies have identified large sets of genes that showed 
differential expression at specific developmental stages. The sets of regulated genes have 
been further explored by various bioinformatic analyses, to learn more about the molecular 
functions of the differentially expressed genes and understand their biology. Here we 
discuss results from studies on cardiomyocyte and hepatocyte differentiation, performed by 
us and others, and report on genes and pathways that showed up- or down-regulation 
particularly during these processes.  
8.1 Molecular signature of hESC-derived cardiomyocyte clusters  
Despite the substantial progress made by different investigators during recent years, the 
understanding of the molecular signature of hESC-derived cardiomyocytes (CMs) and the 
factors that induce cardiogenesis during embryonic development still remains limited. 
However, important knowledge about the transcriptional program that is activated during 
CM differentiation has been gained through transcriptional profiling of these cells 
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(experimental set-up described in section 7.1). Selected colonies of hESC-derived contracting 
clusters of CMs were manually dissected, and pooled for subsequent microarray analysis. 
These samples were compared with samples from UD hESCs. In total 530 up-regulated and 
40 down-regulated genes were identified in the CMCs (Synnergren et al., 2008). Among the 
up-regulated genes, there were several that have been used before to characterize hESC-
derived CMs e.g., MYH6, MYH7, PLN, TNNT2, NPPA, GATA4, and MEF2C (Kehat et al., 
2001, McDevitt et al., 2005). The functional properties of the up-regulated genes in the hESC-
derived CMCs were further investigated, using available Gene Ontology annotations. 
Among the enriched annotations were ‘muscle contraction’, ‘development of mesoderm and 
muscle’, ‘cellular differentiation’, ‘calcium ion binding’, and ‘tropomyosin binding’. 
Moreover, several induced cellular pathways where identified, that may be important for 
cardiogenic induction of hESCs but also for sustaining the CM phenotype. Results reported 
by other investigators show high overlap with our data, despite the fact that direct 
comparisons of results between different microarray studies are sometimes difficult to 
make. Different experiments often have major discrepancies in differentiation models, 
microarray platforms, cell lines used, and experimental set-ups, which partly may explain 
observed problems with poor overlap between published results from different stem cell 
studies (Fortunel et al., 2003, Ivanova et al., 2002, Ramalho-Santos et al., 2002).  
To overcome some of these problems one should preferably re-analyze the data from the 
raw data files from each experiment, using a consistent data mining approach for all the 
data sets, when comparing results from multiple microarray studies. However, as an 
alternative, we have compared published lists of significantly enriched genes from similar 
studies, to explore the overlap of differentially expressed genes during CM differentiation. 
Importantly, in addition to the above mentioned challenges when comparing microarray 
data from different experiments, the final cell populations that have been analyzed in these 
studies differ in their composition (Cao et al., 2008, Xu et al., 2009). Nevertheless, and in 
contrast to previous findings (Fortunel et al., 2003, Ivanova et al., 2002, Ramalho-Santos et 
al., 2002), notable similarities were identified across results from the four global expression 
studies that so far have been published on hESC-derived CM-like cells (Beqqali et al., 2006, 
Cao et al., 2008, Synnergren et al., 2008, Xu et al., 2009). Importantly, this strengthens the 
reliability of the microarray technology and verifies that hESC-derived CMs express a 
uniform transcriptional profile, despite different cell lines and major differences in how 
these cells are derived.  
Comparing results from our data (Synnergren et al., 2008) with the study performed by 
Beqqali et al. (Beqqali et al., 2006), where hESC-derived CMs were generated by co-culture 
with END-2 cells (Passier et al., 2005), 15 genes were reported as enriched in their hESC-
derived CMs and in fetal heart tissue. Notably, eight (53%) of these genes are also up-
regulated in our hESC-derived CMs (e.g. TNNT2, PLN, and MYL7). Another study 
published on hESC-derived CMs (Cao et al., 2008) report on analyses made on material from 
hESCs, hESC-derived beating embryoid bodies (EBs), hESC-derived CMs which were percol 
purified to 40-45% CMs, and purified CMs from fetal heart (FH) tissue samples. Notably, 
their study focused on transitions from one stage to the next one, and consequently they 
compared hESCs-EBs, EBs-CMs, and CMs-FH. In our work we compared hESCs with hESC-
derived CM clusters and the corresponding direct comparison of CMs and hESCs was not 
done by Cao et al. (Cao et al., 2008) which hampers the comparison of our results with 
theirs. Nevertheless, we found that 33% of our up-regulated genes in the CMCs were in 
their study identified as enriched already at the EB stage. Five of our up-regulated genes in 
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the CMCs (EPAS1, ITGB3, PLD1, MSRB3, EMP1) were significantly enriched in FH 
compared to the CM-sample, and six of our genes that were enriched in the CMCs (CLIC5, 
RUNX1, COL8A1, LONRF2, MSRB3, CAV2) were up-regulated in CMs compared to EBs. A 
similar comparison was made regarding the repressed genes across these two studies and 17 
(43%) of the 40 significantly down-regulated genes in our data were already repressed at the 
EB stage in Cao et al., and one gene was among the significantly down-regulated genes 
between FH and CMs. Again, no comparison was made between CMs and hESCs (Cao et 
al., 2008) regarding down-regulated genes, but such a comparison is anticipated to generate 
a higher overlap with our list of genes that were down-regulated in CMCs.  
The most recent work on global gene expression of hESC-derived CMs used a transgenic cell 
line with a construct comprising the CM-restricted α-myosin heavy chain (α-MHC) 
promoter (Xu et al., 2009). They applied antibiotic selection to purify their population of 
hESC-derived CMs and achieved a 99% pure population. Fetal and adult heart tissue were 
used as reference samples but notably, these samples were not purified, but contained a 
mixture of the cell types present in heart tissue. Despite substantial differences, such as 
different cell lines, differentiation protocols, purity of CMs, sampling day etc, a prominent 
overlap was observed between our data and the data from Xu and colleagues (Xu et al., 
2009). In total 147 (27%) of the 540 genes that were up-regulated in our data were also 
identified as significantly up-regulated in their population of CMs, when compared to UD 
and EB samples. Remarkably, 115 (78%) of these 147 genes also show up-regulation in the 
FH and AH samples in data from Xu et al. Strikingly, a subset of 57 genes that show up-
regulation in our hESC-derived CM clusters is also overlapping with the up-regulated genes 
both in Cao et al. (Cao et al., 2008) and in Xu et al (Xu et al., 2009). All of these 57 genes also 
show significantly up-regulation in FH and AH. Furthermore, three (RBM24, TCEA3, and 
FHOD3) of the four novel candidate cardiac markers, which by Xu and co-workers were 
validated by in situ hybridization during early mouse development, were indeed 
significantly up-regulated in our study of hESC-derived CMCs (Synnergren et al., 2008). The 
fourth one (C15orf52) was not present on the arrays we used. Interestingly, TCEA3 is also 
among the 57 genes that overlapped across all three studies (Cao et al., 2008, Synnergren et 
al., 2008, Xu et al., 2009). Taken together, this suggests that there are substantial similarities 
between the CM cell populations obtained from hESCs, independent of differentiation 
protocols and cell lines used. The results summarized here provide valuable information 
about the molecular program that is active in hESC-derived CMs. 
However, to further analyze the regulatory mechanisms that may control CM 
differentiation, an additional level of gene regulation have also been explored (experimental 
set-up described in section 7.2) and hESC-derived CMCs have been characterized with 
respect to their miRNA expression. Global microarrays were employed to measure the 
expression of both miRNA and mRNA in parallel in samples of CMC, harvested at two 
different time points, 3 weeks and 7 weeks after onset of differentiation, as well as in UD 
cells and in fetal and adult heart tissue samples. Differentially expressed miRNAs and 
mRNAs were identified in these datasets, by using UD cells as control sample. Notably 
there were more than twice as many up-regulated than down-regulated miRNAs in the 
samples of CMCs, indicating the importance of increased expression of specific miRNAs 
during cardiac development (Synnergren et al., 2010b). Furthermore, we also identified 
more differentially expressed miRNAs (both up- and down-regulated) in the CMC samples 
than in the fetal and adult heart tissue samples. To define a set of miRNAs of putative 
importance in cardiac-like cells, differentially expressed miRNAs in samples from CMC and 
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in samples from fetal and adult heart were compared, and an overlap of regulated miRNAs 
in all four samples was identified. In total 61 up-regulated and 24 down-regulated miRNAs 
were identified when investigating all four samples (Synnergren et al., 2010b). Moreover, 
possible correlations between differentially expressed miRNAs and mRNAs were 
investigated, by first conducting computational predictions for the differentially expressed 
miRNAs, and then determining putative concordance in miRNA expression and mRNA 
levels of the predicted target genes. Interestingly, a correlation between the global miRNA 
expression and corresponding target mRNA expression was observed. To further explore 
the biology of the predicted target genes of the differentially expressed miRNAs, enrichment 
of Gene Ontology annotations was determined and strikingly, several of the over-
represented annotations relate to cardiac function and cardiac development. A number of 
induced cellular pathways were also identified among the predicted target genes, and 
several of these have been demonstrated to be important in cardiac development or 
functions e.g. ‘NFAT and Hypertrophy of the heart’, ‘Wnt signaling pathway’ and ‘Calcium 
signaling pathway’. Results from this analysis provide an excellent starting point for further 
studies regarding the functional properties of the differentially expressed miRNAs in the 
context of cardiogenesis and regeneration of cardiac tissue.  
Several other studies have also identified a number of miRNAs that are likely to play key 
roles during heart development and in cardiac function (Cordes & Srivastava, 2009, 
Divakaran & Mann, 2008, Sartipy et al., 2009, Thum et al., 2008, van Rooij & Olson, 2007, 
Zhang, 2008). It was recently demonstrated that miR-1 reinforces the expression of one of 
the earliest cardiac markers, NKX2.5, in both murine and human ESC lines and that it 
increases the fraction of contracting CMs compared to control samples (Ivey et al., 2008). 
Another group of miRNAs that are expressed during the stem cell state and progressively 
declines during differentiation are the nearly identical miRNAs miR-302a-d, collectively 
referred to as miR-302 (Rosa et al., 2009). By controlling the germ layer specification and 
promote mesendodermal fate specification while inhibiting neuroectoderm formation, it is 
suggested that miR-302 has a crucial role in embryogenesis (Rosa et al., 2009). In line with 
these reports, our data confirms that several variants of miR-302 are highly expressed in UD 
cells, and a substantial down-regulation is also observed in differentiated progenies as well 
as in fetal and adult heart tissue. Moreover, we identified miR-208a/b and miR-499 as 
significantly induced in all cardiac-like samples. Interestingly, these miRNAs are also 
reported as enriched in cardiac tissue by others (Adachi et al., 2010, Ji et al., 2009, Sluijter et 
al., 2010). Both miRNA-499 and miRNA-1 are suggested to regulate the proliferation of 
human CM progenitors and their further differentiation into CMs (Sluijter et al., 2010). In 
addition, miR-499 is also proposed as a marker for acute myocardial infarction in humans 
(Adachi et al., 2010). Moreover, miR-208 is suggested as a marker for myocardial injury in 
rat (Ji et al., 2009), and as a regulator of cardiac hypertrophy in mice (Callis et al., 2009). 
Together with our results, these reports emphasize the importance of miRNAs for cardiac 
development as well as potentially useful markers in clinical applications. In the future, 
some of these miRNAs may also serve as prospective drug targets in various cardiac 
injuries. There is accumulating evidence supporting the importance of miRNAs for hESC 
self-renewal, pluripotency, and differentiation. Determining miRNAs that are associated 
with re-programming will yield significant insight into the specific miRNA expression 
patterns that are required for pluripotency. To further investigate which miRNAs that are 
associated with re-programming, investigators have now started to characterize the miRNA 
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expression during the re-programming of iPS cells (Wilson et al., 2009). Interestingly, result 
shows that miR-302 is up-regulated in both hESCs and in iPS cells.  
8.2 Transcriptional profiling of hESCs differentiating to definitive and primitive 
endoderm and further towards the hepatic lineage 
The endoderm lineage can be subdivided into the DE which further develops into liver, 
pancreas and lung, and the PrE which develops into the yolksack, where it forms the 
placenta. To explore transcriptional differences between these two subtypes, global gene 
expression data from DE and PrE differentiation was analysed and the transcriptional 
patterns in these two cell lineages were compared with UD cells, as well as with control 
samples from HepG2 (experimental set-up described in section 7.3). Interesting differences 
and similarities were identified between these two endodermal subtypes. We also 
thoroughly characterized the DE-derivatives, by identifying up- and down-regulated genes 
in each of the three differentiation time points 4 days (DE), 10 days (DE-Prog) and 20 days 
(DE-Hep). In total, we identified 167, 439, and 921 transcripts which were significantly up-
regulated in DE, DE-Prog, and DE-Hep, respectively, when compared to UD samples. None 
of these transcripts were significantly enriched in the PrE derivatives. Well-known markers 
for DE, such as SOX17, CXCR4, CER1 and GSC, showed a distinct peak of expression in the 
DE time point in all the three investigated cell lines. At the final time point, when using the 
DE differentiation protocol, several genes known to be expressed in mature hepatocytes, e.g. 
ALB, DPP4, SERPINA7, TF, TM4SF1 and UBD (Chiao et al., 2008, Hay et al., 2008, Kon et al., 
2006), showed increased mRNA levels. Notably, also CD44, known to be expressed in 
hepatocyte progenitors (Kon et al., 2006), showed high expression at 20 days, which 
indicates that the DE-Hep have an immature phenotype or also contain a fraction of 
hepatocyte progenitors. Interestingly, ALB, which is a well-known marker for mature 
hepatocytes (Duncan, 2003), showed 3-11 times higher expression in DE-Hep than in the 
corresponding PrE-derivatives, and the expression of ALB was about 1,000-fold higher in 
the DE-Hep than in the UD samples. Of special note from our results are the less reported 
genes TM4SF1 and UBD, which demonstrate highly interesting expression patterns. Their 
expression patterns were consistent across all three cell lines, indicating a putative 
importance of controlled expression during hepatocyte differentiation. Both these genes 
demonstrate increasing expression levels during the differentiation towards hepatocytes, 
with the peak expression in the most mature samples. Interestingly, and consistent with our 
observations, these genes have also previously been reported as reliable hepatocyte markers 
(D´Amour et al., 2007). Another observation from our results is that the global 
transcriptional activity increases dramatically as the cells differentiate, with a larger number 
of differentially expressed genes in the more mature samples.  
To the best of our knowledge, besides our work (Synnergren et al., 2010a), global 
transcriptional profiling of hESC-derived hepatocytes has only been reported once (Chiao et 
al., 2008), in which AFP+ cells were selected for gene expression analysis. However, the data 
analysis approach used in that study differs from ours and instead of generating lists of up- 
vs. down-regulated genes during hepatocyte differentiation, they applied Gene Set 
Enrichment Analysis (Mootha et al., 2003) to identify affected sets of genes during hepatic 
specification, e.g. molecular pathways etc. An overlap comparison of lists of enriched genes 
in different stages is therefore not possible. However, when investigating the expression of 
30 marker genes, which specifically were reported as enriched in their AFP+ population, we 
observed important similarities between the data sets. Examples of genes that are enriched 
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in the early DE stage in both studies are typical DE-markers such as SOX17, FOXA2 and 
MIXL1. Moreover, AFP, which is expressed during hepatocyte specification but also at very 
early stages of PrE, is up-regulated accordingly in our data. Additionally, CDH17 and KRT7, 
which are reported as expressed during hepatocyte specification (Chiao et al., 2008) are 
induced in our hepatocyte-like cells, which might indicate that this population also contains 
more immature cells. Also other genes such as ALB, NTN4, MET, and CEBPA, which are 
known to be expressed in mature hepatocytes, show induced expression patterns in both 
studies.  
9. Conclusion and future perspectives 
Human ESCs have a tremendous potential in many different applications such as drug 
development, regenerative medicine, and as a model system in basic research. However, to 
fully utilize the potential of these cells we need to better understand the regulatory 
mechanisms that control the differentiation of hESC into various functional cell types. 
Transcriptional profiling is a powerful approach to learn more about the global 
transcriptional pattern in differentiating hESC. In this chapter we have reviewed studies on 
global transcriptional profiling in hESCs and differentiated progenies of the cardiac- and 
hepatic lineages. The comprehensive datasets generated from these studies are especially 
useful for characterization purposes, identification of differentially expressed genes, and 
investigation of gene regulation. We, and others, have performed transcriptional profiling of 
hESC-derived CMs and hepatocytes, and sets of significantly up- and down-regulated genes 
in different stages during the differentiation processes have been identified. Interesting 
transcriptional patterns have been revealed, which confirms the expression of known 
marker genes as well as identifies large sets of novel genes that are differentially expressed 
at particular stages during the differentiation. The expected expression patterns of known 
marker genes is important information to confirm the efficiency of the differentiation, but 
most interesting are the novel sets of genes that not previously have been associated with 
differentiation or developmental processes. It is hypothesized that many of these genes have 
the potential to serve as novel markers and provide important information for optimization 
of the differentiation protocols, and further validation and investigation of their functional 
properties is therefore suggested.  
Less studied than mRNA expression is the miRNA expression, which has shown to be 
important in stem cell specification. These tiny molecules provide an additional level of 
gene regulation by fine-tuning of the mRNA expression. An interesting approach to identify 
putative correlations between these interacting molecules is to explore the miRNA and 
mRNA expression in parallel, which has revealed interesting result when applied on data 
from hESC-derived CMs. MicroRNA expression may also provide a novel characterization 
of hESC-derivatives and results from studies on CMs show that specific miRNAs may serve 
as important complementary markers for this specific cell type. However, additional studies 
on the miRNA expression in other derivatives are needed to be able to compare the 
expression in different cell types, and ideally identify lineage specific miRNA patterns.  
During the last decade the microarray technology has improved considerably and the recent 
development of whole transcript arrays has rendered the possibility to also explore different 
splicing variant genes. This is an important step forward since it is anticipated that more 
than half of all genes undergo alternative splicing. However, the data analysis of exon data 
sets are demanding and tools for proper interpretation of such data is still rare and 
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insufficient. Nevertheless, splicing variations are believed to be important in many disease 
and their function in stem cell differentiation remains to be investigated. The most recent 
progress in the field of human pluripotent stem cells is successful re-programming of 
differentiated somatic cells into induced pluripotent stem (iPS) cells (Takahashi et al., 2007). 
Human iPS-cells are generated from somatic cells by over-expression of specific factors and 
these cells share many characteristics of hESCs, including multi-lineage differentiation 
potential and infinitive proliferation capabilities in vitro. However, extensive 
characterization of the iPS cells and their differentiated progenies at the transcriptional level 
is still lacking, but it is nevertheless required to be able to assess their similarity to hESCs.  
Taken together, transcriptional profiling of hESC and their derivatives offers great 
possibilities to explore global expression patterns that are activated during hESC 
differentiation, and provide a foundation for further dissection of the molecular 
mechanisms that control the stem cell specification. 
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